These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Importance of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired pneumonia]. Sáez-Llorens X, Castaño E, Wubbel L, Castrejón MM, de Morales I, Vallarino D, de Atencio I, Muñiz L, Olsen K, McCracken GH. Rev Med Panama; 1998 Sep; 23(2):27-33. PubMed ID: 11214557 [Abstract] [Full Text] [Related]
3. Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children. Harris JA, Kolokathis A, Campbell M, Cassell GH, Hammerschlag MR. Pediatr Infect Dis J; 1998 Oct; 17(10):865-71. PubMed ID: 9802626 [Abstract] [Full Text] [Related]
5. Etiology and response to antibiotic therapy of community-acquired pneumonia in French children. Gendrel D, Raymond J, Moulin F, Iniguez JL, Ravilly S, Habib F, Lebon P, Kalifa G. Eur J Clin Microbiol Infect Dis; 1997 May; 16(5):388-91. PubMed ID: 9228482 [Abstract] [Full Text] [Related]
6. Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: a randomized study of amoxicillin-clavulanate and ceftriaxone. Rosón B, Carratalà J, Tubau F, Dorca J, Liñares J, Pallares R, Manresa F, Gudiol F. Microb Drug Resist; 2001 May; 7(1):85-96. PubMed ID: 11310807 [Abstract] [Full Text] [Related]
8. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children. Mulholland S, Gavranich JB, Gillies MB, Chang AB. Cochrane Database Syst Rev; 2012 Sep 12; (9):CD004875. PubMed ID: 22972079 [Abstract] [Full Text] [Related]
9. Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis. Langley JM, Halperin SA, Boucher FD, Smith B, Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC). Pediatrics; 2004 Jul 12; 114(1):e96-101. PubMed ID: 15231980 [Abstract] [Full Text] [Related]
10. Penicillin G/ofloxacin versus erythromycin/amoxicillin-clavulanate in the treatment of severe community-acquired pneumonia. Gaillat J, Bru JP, Sedallian A. Eur J Clin Microbiol Infect Dis; 1994 Aug 12; 13(8):639-44. PubMed ID: 7813493 [Abstract] [Full Text] [Related]
12. Community-acquired pneumonia in infants and children. Ostapchuk M, Roberts DM, Haddy R. Am Fam Physician; 2004 Sep 01; 70(5):899-908. PubMed ID: 15368729 [Abstract] [Full Text] [Related]
17. Effects of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media. Ghaffar F, Muniz LS, Katz K, Reynolds J, Smith JL, Davis P, Friedland IR, McCracken GH. Clin Infect Dis; 2000 Oct 01; 31(4):875-80. PubMed ID: 11049764 [Abstract] [Full Text] [Related]
18. Childhood community-acquired pneumonia. Ruuskanen O, Mertsola J. Semin Respir Infect; 1999 Jun 01; 14(2):163-72. PubMed ID: 10391410 [Abstract] [Full Text] [Related]
19. Atypical and Typical Bacteria in Children with Community Acquired Pneumonia. Jama-Kmiecik A, Frej-Mądrzak M, Sarowska J, Teryks-Wołyniec D, Skiba A, Choroszy-Król I. Adv Exp Med Biol; 2019 Jun 01; 1160():65-71. PubMed ID: 31016635 [Abstract] [Full Text] [Related]
20. Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. Marrie TJ, Peeling RW, Fine MJ, Singer DE, Coley CM, Kapoor WN. Am J Med; 1996 Nov 01; 101(5):508-15. PubMed ID: 8948274 [Abstract] [Full Text] [Related] Page: [Next] [New Search]